← Back to Home
Intraday·Markets Desk·Yesterday
Intraday Calls: SBICARD, HAL and 18 More in Focus
Prakash Gaba and 10 other SEBI-registered analysts issued 31 intraday recommendations across 20 stocks for single-session action, with a broadly bullish bias.
By Markets Desk·31 Calls·28 Buy, 3 Sell
Prakash Gaba and 10 other SEBI-registered analysts issued 31 equity intraday recommendations today, targeting single-session price action before market close at 3:30 PM IST. The batch carries a broadly bullish bias — 28 buys against 3 sells — covering 20 stocks.
The 5 most-covered names of the session:
SBICARD attracted 4 buys from Prakash Gaba (SEBI Reg. INH000001022) — a buy at ₹670 targeting ₹680 (stop ₹664), a buy at ₹670 targeting ₹690 (stop ₹664), a buy at ₹674 targeting ₹680 (stop ₹664), a buy at ₹674 targeting ₹690 (stop ₹664).
HAL attracted 3 buys from Manas Jaiswal (SEBI Reg. INH100001625) — a buy at ₹5,012 targeting ₹5,050 (stop ₹4,959), a buy at ₹5,012 targeting ₹5,125 (stop ₹4,959), a buy at ₹4,974 targeting ₹5,050 (stop ₹4,899).
TORNTPHARM attracted 3 separate recommendations from 2 SEBI-registered analysts — Prakash Gaba (SEBI Reg. INH000001022) issued 2 buys at ₹4,979 targeting ₹5,000 and ₹5,050 (stop ₹4,962); Integratedresearchchannel (SEBI Reg. INH200006530) issued a sell at ₹4,901.5, targeting ₹4,839 (stop ₹4,949).
AUROPHARMA attracted 2 buys from KotakSecurities (SEBI Reg. INH000000586) at ₹1,682.3 and ₹1,682.3, each targeting ₹1,696 (stop ₹1,662).
DIVISLAB attracted 2 buys from KotakSecurities (SEBI Reg. INH000000586) at ₹9,411 and ₹9,411, each targeting ₹9,485 (stop ₹9,298).
The remaining 15 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — INDOAMIN (₹962 → ₹982) via STOCKGAINERSS; OIL (₹492.5 → ₹499) via KotakSecurities; APOLLOHOSP (₹8,819 → ₹8,850) via Prakash Gaba; ASHOKLEY (₹170 → ₹175) via Amit Seth; BEL (₹411 → ₹420) via Prudentbroking; CANBK (₹124.65 → ₹125.9) via Integratedresearchchannel; CHOLAFIN (₹1,818 → ₹2,140) via HSBC; KIRLOSENG (₹2,265 → ₹2,300) via Prudentbroking.
LAURUSLABS (₹1,902 → ₹1,890.5) via Jainamresearch; NYKAA (₹340 → ₹350) via Amit Seth; PERSISTENT (₹5,560 → ₹5,595.5) via Integratedresearchchannel; TRITURBINE (₹580 → ₹610) via Jay Thakkar; WSTCSTPAPR (₹692.5 → ₹699) via Integratedresearchchannel.
Sell calls — ADANIENT (₹2,931 → ₹2,750) via Somil Mehta; APOLLOTYRE (₹418 → ₹415) via Integratedresearchchannel.
This roundup reproduces calls from 11 SEBI-registered Research Analysts: Prakash Gaba (SEBI Reg. INH000001022); KotakSecurities (SEBI Reg. INH000000586); Integratedresearchchannel (SEBI Reg. INH200006530); Manas Jaiswal (SEBI Reg. INH100001625); Amit Seth (SEBI Reg. INH300009172); Prudentbroking (SEBI Reg. INH000018115); STOCKGAINERSS (SEBI Reg. INH100007879); HSBC (SEBI Reg. INH000001287); Jainamresearch (SEBI Reg. INH000006448); Jay Thakkar (SEBI Reg. INH000000990); Somil Mehta (SEBI Reg. INH000006183).
Intraday calls carry elevated risk and require active monitoring. All positions should be squared off before 3:30 PM IST unless the issuing analyst specifies otherwise.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
SEBI-Registered Research Analysts
Prakash Gaba · SEBI Reg. INH000001022KotakSecurities · SEBI Reg. INH000000586Integratedresearchchannel · SEBI Reg. INH200006530Manas Jaiswal · SEBI Reg. INH100001625Amit Seth · SEBI Reg. INH300009172Prudentbroking · SEBI Reg. INH000018115STOCKGAINERSS · SEBI Reg. INH100007879HSBC · SEBI Reg. INH000001287Jainamresearch · SEBI Reg. INH000006448Jay Thakkar · SEBI Reg. INH000000990Somil Mehta · SEBI Reg. INH000006183
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.